Prevalence and Interpretation of Recent Trends in
Rates of Pervasive Developmental Disorders by Fombonne, Eric et al.




The  studies  were  identified  through  systematic
searches from the major scientific literature databases
and from prior reviews (1-3). Only studies published in
the English language were included. Overall, 57 studies
published between 1966 and 2009 were selected which
surveyed PDDs in 17 countries; half of the studies have
been  published  since  2001.The  age  range  of  the
population included in the surveys is spread from birth
to  early  adult  life,  but  most  studies  have  relied  on
school-aged samples. There was huge variation in the
size  of  the  population  surveyed  (mean:  279,000;
median: 44,900).
Study Designs
In designing a prevalence study, two major features
are critical for the planning and logistics of the study, as
well  as  for  the  interpretation  of  its  results:  case
definition,  and  case  ascertainment  (or  case
identification methods) (4).
Case Definition
Over  time,  the  definitions  of  autism  have  changed  as
illustrated by the numerous diagnostic criteria that were used in
both epidemiological and clinical settings. The first diagnostic
criteria reflected the more qualitatively severe forms of autism
and it is only in the 1980s that less severe forms of autism were
recognized, either as a qualifier for autism occurring without
mental retardation or as separate diagnostic categories within a
broader class of autism spectrum disorders (ASD) denominated
‘Pervasive  developmental  disorders’  (PDD,  an  equivalent  to
ASD) in current nosographies. Current nosographies include the
Diagnostic and Statistical Manual of Mental Disorders, Fourth
edition, Text Revision (DSMIV- TR) (5) and the International
Classification of Diseases, Tenth edition (ICD-10) (6). Whilst
there  is  generally  high  agreement  among  experts  on  the
diagnosis  of  PDD’s,  some  differences  persist  between
nomenclatures  about  the  terminology  and  precise  criteria  of
PDD’s. In addition, in recent years, the definitions of syndromes
falling on the autism spectrum have been expanded further with
reference to the broader autism phenotype, which is a pattern of
mild  autistic  developmental  symptoms  seen  in  relatives  of
individuals affected with a diagnosed PDD. As no diagnostic
criteria  are  available  for  these  mild  forms  of  autism,  the
resulting  boundaries  with  the  spectrum  of  PDDs  are  left
uncertain.  Whether  or  not  this  plays  a  role  in  more  recent
epidemiological studies is difficult to know, but it is a possibility
that  should  be  considered  in  assessing  results  for  the  new
generation of surveys.
Case Identification
When an area or population have been identified for a survey,
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some  studies  have  solely  relied  on  existing  service
providers  databases  (7);  on  special  educational
databases (8,9,10 ); or, on national registers (11) for
case  identification.  These  studies  have  the  common
limitations due to relying on local access to existing
services  for  case  ascertainment. As  a  result,  subjects
with  the  disorder  who  are  not  in  contact  with  these
services  are  not  included  as  cases,  leading  to  an
underestimation of the prevalence proportion.
Other  investigations  have  relied  on  a  multi-stage
approach  to  identify  cases.  The  aim  of  the  first
screening stage of these studies is to cast a wide net in
order to identify subjects possibly affected with a PDD,
with the final diagnostic status being determined at a
next phase. Then, subjects identified as positive screens
go through a more in-depth evaluation to confirm their
case status. The source of information used to determine
whether an individual has a PDD usually involved a
combination  of  data  coming  from  different  sources
(medical  records,  educational  sources,  other  health
professionals,  etc..),  with  a  direct  assessment  of  the
person with autism being offered in some but not all
studies. Obviously, surveys of very large populations
did  not  include  a  direct  diagnostic  assessment  of
subjects, as in the studies conducted in the US by the
Center for Disease Control (CDC) (12,13) or in national
registers (11). However, investigators could generally
confirm the accuracy of the diagnosis of their cases by
undertaking, on randomly selected subsamples, a more
complete diagnostic workup.
When subjects were directly examined, assessments
were  conducted  with  various  diagnostic  instruments,
ranging from a typical unstructured examination by a
clinical  expert  (without  demonstrated  psychometric
properties),  to  the  use  of  batteries  of  standardized
measures  by  trained  research  staff.  The  Autism
Diagnostic Interview (14) and/or the Autism Diagnostic
Observational  Schedule  (15)  have  been  increasingly
used in the most recent surveys.
PREVAlENCE ESTIMATIONS
Autistic Disorder
Prevalence  estimates  for  autistic  disorder  are
summarized in Table 1. There were 47 studies, half of
them published since 1999, and the sample size varied
from  826  to  4.95  millions,  with  a  median  of  38,000
(mean: 217,000) subjects in the surveyed populations.
The age ranged from 3 to 15 years, with a median age
of 8.5 years. The male/female ratio ranged from 1.33 to
16.0 in 39 studies, leading to an average male/female
ratio of 4.3:1. Prevalence rates varied from 0.7/10,000
to  72.6/10,000  with  a  median  value  of  12.7/10,000.
Small-scale studies reported higher prevalence rates. A
significant positive correlation between prevalence rate
and year of publication was found. Therefore, a current
estimate for the prevalence of autistic disorder must be
derived  from  more  recent  surveys  with  an  adequate
sample size. After exclusion of 4 studies with the smallest
and largest sample sizes, the best current estimate for
autistic disorder is 22/10,000. In 25 studies where the
proportion of subjects with IQ within the normal range
was reported, the median value was 20% (interquartile
range:  17.5%-50%).  In  these  surveys,  there  was  a
significant  correlation  between  a  higher  proportion  of
normal  IQ  subjects  and  a  higher  male/female  ratio
(Spearman’s r: 0.53; p=007), a result consistent with the
association between gender and IQ in autism. Over time,
there  were  minor  associations  between  the  year  of
publication of the survey and the sample male/female
ratio (Spearman’s r: 0.33; p=.039) and the proportion of
subjects without mental retardation (Spearman’s r: 0.34;
p=.094). Taken in conjunction with the much stronger
increase  over  time  in  prevalence  rates,  these  results
suggest  that  the  increase  in  prevalence  rates  is  not
entirely accounted for by the inclusion of milder forms
(i.e. less cognitively impaired) of autistic disorder, albeit
this might have contributed to it to some degree.
Asperger Syndrome
Epidemiological studies of Asperger Syndrome (AS)
are sparse, due to the fact that it was acknowledged as a
separate  diagnostic  category  only  recently.  Twelve
studies (already listed in Table 1) published since 1998,
have examined samples with respect to the presence of
both  autistic  disorder  and  Asperger  Syndrome.  The
median population size was 200,000 and the median age
8.25 years. The number of children with AS varied from
6 to 427, with a median sample size of 38. There was a
160-fold variation in estimated rates of AS (range: 0.3
to 48.4/10,000) that highlights the lack of reliability of
these estimates. The median value was 11.0/10,000. The
prevalence ratio (autistic disorder/ Asperger Syndrome)
had a median value of 2.05, indicating that the rate of
AS was consistently lower than that for autism. The
epidemiological  data  on  AS  are  of  dubious  quality,
reflecting difficult nosological issues as well as lack of
proper  measurement  strategies  that  ensure  a  reliable
difference between AS and autistic disorder.
Childhood Disintegrative Disorder
Eleven  surveys  have  provided  data  on  childhood
disintegrative disorder (CDD). In 5 of these, only 1 case
was reported. Prevalence estimates ranged from 0 to
9.2/100,000,  with  a  median  rate  of  2.0/100,000. The
pooled  estimate  based  on  11  identified  cases  and  a
surveyed  population  of  about  604,000  children,  was
1.8/100,000.ASD prevalence 101 Vol. 12  No. 2
PREVAlENCE FOR COMBINED PDDS
Unspecified Autism Spectrum Disorders in 
Earlier Surveys
Several studies performed in the 1960’s and 1970’s
have provided useful information on rates of syndromes
similar to autism but not meeting of the strict diagnostic
criteria for autistic disorder then in use (1,2). At the
time,  different  labels  were  used  by  authors  to
characterize these clinical pictures, such as the triad of
impairments  involving  deficits  in  reciprocal  social
interaction, communication, and imagination ( 16 ), and
among others, autistic mental retardation (17). These
syndromes  would  be  falling  within  our  currently
defined  autistic  spectrum,  probably  with  diagnostic
labels  such  as  atypical  autism  and/or  pervasive
developmental  disorder  –  not  otherwise  specified
(PDD-NOS).  In  8  of  12  surveys  providing  separate
estimates  of  the  prevalence  of  these  developmental
disorders, higher rates for the atypical forms were found
compared to those for more narrowly defined autistic
disorder (see Fombonne, 2003, Table 3, p.172 (1)). This
Table 1: Prevalence surveys of autistic disorder102 MJM Focus 2009
group  received  little  attention  in  previous
epidemiological  studies  and  these  subjects  were  not
counted in the numerators of prevalence calculations,
thereby underestimating systematically the prevalence
of  what  would  be  defined  today  as  the  spectrum  of
autistic disorders. For example, in Wing et al.’s study
(1976) (18), the prevalence was 4.9/10,000 for autistic
disorder,  but,  adding  the  figure  of  16.3/10,000  (16)
corresponding  to  the  triad  of  impairments,  the
prevalence  for  the  whole  PDD  spectrum  was  in  fact
21.1/10,000. For historical purposes, it is important to
be attentive to this earlier figure, bearing in mind that
the study was conducted in the early 1970s and that
autism  occurring  in  subjects  with  an  IQ  within  the
normal  range  was  not  yet  being  investigated.
Progressive  recognition  of  the  importance  and
relevance  to  autism  of  these  less  typical  clinical
presentations has led to changes in the design of more
recent  epidemiological  surveys  (see  below),  that  are
now  using  case  definitions  that  incorporate  upfront
these milder phenotypes.
Newer Surveys of PDDs
The results of surveys that estimated the prevalence of
the whole spectrum of PDDs are summarized in Table
2. Of the 23 studies listed, 13 also provided separate
estimates for autistic disorder (see Table 1) and other
types of PDD; 10 studies provided only an estimated
rate for all the PDDs combined. Sample sizes ranged
from  2,536  to  4,247,206  (median:  32,568;  mean:
270,026) and the median age of samples ranged from
5.0 to 12.5. The diagnostic criteria used in the studies
listed in Table 2 reflect reliance on modern diagnostic
schemes, such as the DSM-IV (19), the DSM-IV-TR (5)
and the ICD-10 (6). In 14 studies where IQ data were
reported, the proportion of subjects within the normal
IQ range varied from 30% to 85.3% (median: 54.4%;
mean: 55.7%), a proportion that is higher than that for
autistic  disorder  and  reflects  the  lesser  degree  of
association,  or  lack  thereof,  between  intellectual
impairment  and  milder  forms  of  PDD’s.  The
male/female ratio ranged from 2.7 to 15.7 (mean: 5.5).
There was a 6-fold variation in prevalence proportions
among studies. The median rate was 61.9/10,000 and
the  mean  rate  was  66.6/10,000.  This  mean  rate
coincides with the rate reported recently for PDDs in 14
sites, in a large sample of 8-year-old US children born
in 1994 (13). The CDC value represents, however, an
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average, and that study conducted at 14 different sites
utilizing  the  same  methodology  found  a  three-fold
variation of rate by state (13). Alabama had the lowest
rate of 3.3/1,000 whereas New-Jersey had the highest
value  with  10.6/1,000  (13).  As  surveillance  efforts
continue, it is likely that awareness and services will
develop in states that were lagging behind, resulting in
a predictable increase in the average rate for the US as
time  elapses.  These  CDC  findings  apply  to  other
countries as well, and prevalence estimates from any
study should always be regarded in the context of the
imperfect sensitivity in case ascertainment that results
in downward biases in prevalence proportions. 
In conclusion, the convergence of estimates around 60
to  70  per  10,000  for  all  PDDs  combined,  which
translates into 1 child out of 150 suffering from a PDD,
is striking especially when derived from studies with
improved methodology. This is the best estimate for the
prevalence of PDDs currently available; however, this
represents  an  average  figure  and  there  is  substantial
variability  across  studies,  and  within  studies,  across
sites  or  areas.  However,  some  studies  have  reported
rates that are even two to three times higher (20, 21).
TIME TRENDS IN PREVAlENCE AND THEIR
INTERPRETATION
The debate on the hypothesis of a secular increase in
rates of autism has been obscured by a lack of clarity in
the  measures  used  by  investigators  to  determine  the
occurrence of disease, or rather in their interpretation.
Methodological  requirements  must  be  borne  in  mind
whilst reviewing the evidence for a secular increase in
rates of PDDs, or testing for the epidemic hypothesis.
Several approaches to assess the question concerning a
secular increase have been used in the literature that fall
into 5 broad categories.
a. Use of Inappropriate Referral Statistics
Increasing numbers of children referred to specialist
services or known to special education registers have
been taken as evidence for an increased incidence of
autismspectrum  disorders.  Upward  trends  in  national
registries, medical and educational databases have been
seen  in  many  different  countries  (8,11,  22,  23).
However,  trends  over  time  in  referred  samples  are
confounded by many factors such as referral patterns,
availability  of  services,  heightened  public  awareness,
decreasing age at diagnosis and changes over time in
diagnostic concepts and practices, to name only a few.
Failure  to  control  for  these  confounding  factors  was
obvious in some recent reports (24), such as the widely
quoted  reports  from  California  Developmental
Database Services (25, 26). Firstly, these reports applied
to numbers rather than rates, and failure to relate these
numbers  to  meaningful  denominators  left  the
interpretation of an upward trend vulnerable to changes
in  the  composition  of  the  underlying  population.
Second,  the  focus  on  the  year-to-year  changes  in
absolute numbers of subjects known to California state-
funded  services  detracts  from  more  meaningful
comparisons. Third, with one exception (see below), no
attempt was made to adjust the trends for changes in
diagnostic  concepts  and  definitions.  Fourth,  age
characteristics  of  the  subjects  recorded  in  official
statistics were portrayed in a confusing manner where
the preponderance of young subjects was presented as
evidence of increasing rates in successive birth cohorts
(24).  Fifth,  the  decreasing  age  at  diagnosis  leads  to
increasing numbers of young children being identified
in  official  statistics  (27)  or  referred  to  already  busy
specialist services. Please see Fombonne, Quirke and
Hagen (in press) (28) for a more elaborate analysis of
these factors.
b. The Role of Diagnostic Substitution
One possible explanation for increased numbers of a
diagnostic category is that children presenting with the
same developmental disability may receive at one time
one  diagnosis,  and  later  another  diagnosis.  Such
substitution may occur when diagnostic categories are
becoming increasingly known and recognized by health
professionals and/or when access to better services is
insured  by  using  a  new  diagnostic  category.  The
strongest  evidence  of  “diagnostic  switching”  was
produced  in  all  US  states  in  a  complex  analysis  of
Department  of  Education  Data  in  50  US  states  (23),
indicating that a relatively high proportion of children
previously diagnosed as having mental retardation were
now  identified  as  having  a  PDD  diagnosis.  Shattuck
(2006) (23) showed that the odds of being classified in
autism category increased by 1.21 during 1994-2003. In
the meantime, the odds decreased significantly of being
classified  in  the  learning  disability  (LD)  (odds  ratio:
OR=0.98) and the mental retardation (MR) categories
(OR=0.97).  However,  this  investigation  has  largely
relied on ecological, aggregated data that have known
limitations. Using individual level data, a new study has
re-examined the hypothesis of diagnostic substitution in
the  California  DDS  dataset  (29)  and  has  shown  that
24%  of  the  increase  in  caseload  was  attributable  to
diagnostic  substitution  from  mental  retardation  to
autism. Similarly, a recent study in the UK (30) has
shown that up to 66% of adults previously diagnosed as
children with developmental language disorders would
meet diagnostic criteria for a broad definition of PDD.
c. Comparison of Cross-Sectional Epidemiological
Surveys
As shown earlier, epidemiological surveys of autism
each  possess  unique  design  features  which  could104 MJM Focus 2009
account almost entirely for variations in rates among
studies, and time trends in rates of autism are therefore
difficult to gauge from published prevalence rates. The
significant  correlation  previously  mentioned  between
prevalence  rate  and  year  of  publication  for  autistic
disorder could merely reflect increased efficiency over
time in case identification methods used in surveys as
well as changes in diagnostic concepts and practices
(23, 30, 31, 32, 33). In studies using capture-recapture
methods, a statistical method for indirectly estimating
prevalence, it is apparent that up to a third of prevalent
cases may be missed by an ascertainment source, even
in recently conducted studies (34). Evidence that factors
due to study methodology could account for most of the
variability  in  published  prevalence  estimates  comes
from a direct comparison of 8 recent surveys conducted
in the UK and the USA (2). In each country, 4 surveys
were conducted around the same year and with similar
age  groups.  As  there  is  no  reason  to  expect  huge
differences in rates across areas, prevalence estimates
should  therefore  be  comparable  within  each  country.
However, there was a six-fold variation in rates for UK
surveys, and a fourteen-fold variation in US rates. In
each  set  of  studies,  high  rates  derived  from  surveys
where intensive population-based screening techniques
were employed whereas lower rates were obtained from
studies relying on passive administrative methods for
case finding. Since no passage of time was involved, the
magnitude  of  these  gradients  in  rates  can  only  be
attributed to differences in case identification methods
across surveys. Even more convincing evidence comes
from the large survey by the CDC (13) where there was
more than a three-fold variation in state specific rates
(see  above).  However,  the  substantial  differences
reflected  ascertainment  variability  across  sites  in  a
study  that  was  otherwise  performed  with  the  same
methods and at the same time. Thus, no inference on
trends in the incidence of PDDs can be derived from a
simple comparison of prevalence rates over time, since
studies conducted at different periods are likely to differ
even more with respect to their methodology.
d. Repeat Surveys in Defined Geographical Areas
Repeated surveys, using the same methodology and
conducted  in  the  same  geographical  area  at  different
points in time, can potentially yield useful information
on time trends provided that methods are kept relatively
constant. The G￶teborg studies (35,36) provided three
prevalence  estimates  which  increased  over  a  short
period  of  time  from  4.0  (1980)  to  6.6  (1984)  and
9.5/10,000 (1988) (36). However, comparison of these
rates is not straightforward as different age groups were
included  in  each  survey.  Secondly,  the  increased
prevalence  in  the  second  survey  was  explained  by
improved detection among the mentally retarded, and
that  of  the  third  survey  by  cases  born  to  immigrant
parents. That the majority of the latter group was born
abroad suggests that differential migration into the area
could be a key explanation. Taken in conjunction with a
change in local services and a progressive broadening
of the definition of autism over time acknowledged by
the authors (36), these findings do not provide evidence
for an increased incidence in the rate of autism. Two
separate surveys of children born 1992-1995 and 1996-
1998  in  Staffordshire  in  the  UK  (37,  38)  were
performed with rigorously identical methods for case
definition and case identification. The prevalence for
combined PDDs was comparable and not statistically
different in the 2 surveys (38), suggesting no upward
trend in overall rates of PDDs, at least during the short
time interval between studies.
e. Successive Birth Cohorts
In  large  surveys  encompassing  a  wide  age  range,
increasing  prevalence  rates  among  most  recent  birth
cohorts  could  be  interpreted  as  indicating  a  secular
increase in the incidence of the disorder, provided that
alternative explanations can confidently be eliminated.
This approach was used in two large French surveys
(39, 40). The surveys included birth cohorts from 1972
to 1985 (735,000 children, 389 of whom had autism),
and, pooling the data of both surveys, age-specific rates
showed no upward trend (40). An additional example is
provided  in  the  analysis  of  Gurney  and  colleagues’
(2003) (8) study in which a sixteen-fold increase in the
number of children identified with a PDD from 1991-
1992  to  2001-2002  was  shown  to  not  be  specific  to
autism since, during the same period, an increase of
50%  was  observed  for  all  disability  categories
identified.  In  addition,  the  analysis  also  showed  a
marked period effect that identified the early 1990s as
the period where rates started to increase in all ages and
birth cohorts.
CONClUSION
The recent upward trend in rates of prevalence cannot
be directly attributed to an increase in the incidence of
the disorder, or to an ‘epidemic’ of autism. There is
good  evidence  that  changes  in  diagnostic  criteria,
diagnostic  substitution,  changes  in  the  policies  for
special  education,  and  the  increasing  availability  of
services  are  responsible  for  the  higher  prevalence
figures.  The  rise  in  number  of  children  diagnosed
occurred  at  the  same  time  in  many  countries,  when
radical  shifts  occurred  in  the  ideas,  diagnostic
approaches  and  services  for  children  with  PDDs.
Alternatively, this might, of course, reflect the effect of
environmental  influences  operating  simultaneously  inASD prevalence 105 Vol. 12  No. 2
different parts of the world. However, there has been no
proposed and legitimate risk mechanism to account for
this  world-wide  effect.  Most  of  the  existing
epidemiological  data  are  inadequate  to  properly  test
hypotheses on changes in the incidence of autism in
human populations. Moreover, due to the relatively low
frequency  of  autism  and  PDDs,  variations  of  small
magnitude  in  the  incidence  of  the  disorder  are  very
likely to go undetected. Equally, the possibility that a
true increase in the incidence of PDDs has also partially
contributed  to  the  upward  trend  in  prevalence  rates
cannot,  and  should  not,  be  eliminated  based  on
available data.
From recent studies, a best estimate of 60 to 70/10,000
(equivalences = 6 to 7/1,000; or 0.6 to 0.7%; or 1 child
in about 150 children) can be confidently derived for the
prevalence  of  autism  spectrum  disorders.  Current
evidence does not strongly support the hypothesis of a
secular  increase  in  the  incidence  of  autism,  but
statistical  power  to  detect  time  trends  is  seriously
limited in existing datasets. To assess whether or not the
incidence has increased, method factors which account
for an important proportion of the variability in rates
must be tightly controlled. New survey methods have
been  developed  to  be  used  in  multinational
comparisons, and ongoing surveillance programs will
inform soon this hypothesis. Meanwhile, the available
prevalence  figures  carry  straightforward  implications
for  current  and  future  needs  in  services  and  early
educational intervention programs.
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